Balance Sheet

Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

InspireMD (NSPR) Preferred Shares Repurchased (2018)

InspireMD filings provide 1 years of Preferred Shares Repurchased readings, the most recent being $3.8 million for Q3 2018.

On a quarterly basis, Preferred Shares Repurchased changed N/A to $3.8 million in Q3 2018 year-over-year; TTM through Dec 2018 was $3.0 million, a N/A change, with the full-year FY2018 number at $3.0 million, changed N/A from a year prior.
Preferred Shares Repurchased hit $3.8 million in Q3 2018 for InspireMD, up from -$300000.0 in the prior quarter.
In the past five years, Preferred Shares Repurchased ranged from a high of $3.8 million in Q3 2018 to a low of -$450000.0 in Q1 2018.